IRAK-1-4 Inhibitor I
≥99%
- Product Code: 101040
CAS:
509093-47-4
| Molecular Weight: | 395.41 g./mol | Molecular Formula: | C₂₀H₂₁N₅O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
IRAK-1-4 Inhibitor I is primarily used in research settings to study the role of IRAK (Interleukin-1 Receptor-Associated Kinase) enzymes in immune signaling pathways. It is particularly valuable in investigating inflammatory and autoimmune diseases, as IRAK proteins play a critical role in mediating immune responses. By inhibiting IRAK-1-4, researchers can better understand the molecular mechanisms underlying conditions like rheumatoid arthritis, lupus, and sepsis. Additionally, this inhibitor is utilized in cancer research to explore its potential in blocking tumor-promoting inflammation and enhancing the efficacy of other cancer therapies. Its application extends to drug development, where it serves as a tool to identify and validate new therapeutic targets for inflammatory disorders and cancer.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $332.65 |
+
-
|
| 0.010 | 10-20 days | $456.07 |
+
-
|
IRAK-1-4 Inhibitor I
IRAK-1-4 Inhibitor I is primarily used in research settings to study the role of IRAK (Interleukin-1 Receptor-Associated Kinase) enzymes in immune signaling pathways. It is particularly valuable in investigating inflammatory and autoimmune diseases, as IRAK proteins play a critical role in mediating immune responses. By inhibiting IRAK-1-4, researchers can better understand the molecular mechanisms underlying conditions like rheumatoid arthritis, lupus, and sepsis. Additionally, this inhibitor is utilized in cancer research to explore its potential in blocking tumor-promoting inflammation and enhancing the efficacy of other cancer therapies. Its application extends to drug development, where it serves as a tool to identify and validate new therapeutic targets for inflammatory disorders and cancer.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :